Cartesian Therapeutics

We are at the @MDAorg congress this week. Come see our poster to hear more about our work in #myastheniagravis which was recently published in Nature Medicine! This will be our first time presenting this at a medical meeting. See our publications here: bit.ly/4ucQQCG

Today we reported full year 2025 financial results and provided a business update. Full press release: bit.ly/4cClHSW #celltherapy #autoimmunity

Tune in tomorrow at 10:00 am ET to hear our fireside chat at the Leerink Global Healthcare Conference in Miami, FL. Listen to the webcast here: bit.ly/3N6Fkbd

Tune in tomorrow at 11:50 am ET to hear our presentation at the TD Cowen 46th Annual Health Care Conference in Boston, MA. Listen to the webcast here: bit.ly/4cMIVWf

Our commitment to patients is at the heart of everything we do. We recently spoke with Cheryl about her experience navigating and managing an MG diagnosis. To view Cheryl’s full interview, please visit: bit.ly/3ZZ693X #RareDiseaseDay #LightUpForRare #ShareYourColors

Looking forward to attending three upcoming investor conferences, where we’re discussing exciting company milestones ahead as we work to expand the reach of #celltherapy to #autoimmunedisease. Information here: bit.ly/4rtu7QT

Thank you @DsLevine, for hosting us on #RareCAST, where we discussed our potential #celltherapy, data from our phase 2 study in myasthenia gravis, and the opportunity to expand the approach into #myositis and other rare autoimmune indications. To listen: bit.ly/4csIvUQ

Myasthenia gravis (MG) is a chronic #autoimmune disorder that causes disabling muscle weakness and fatigue. Learn more about this #RareDisease directly from people living with MG and how this has affected their daily lives. Full interview: bit.ly/4rMvx99

We recently hosted @FrederickCC's Biotech Bootcamp, a free program designed to provide immersive theory, hands-on training, and the practical tools needed to successfully transition into the biotech industry, strengthening the regional biotech #community. #Lifesciences

Check out our recent publications in @NatureMedicine, detailing the mechanism of action (MOA) of Descartes-08, and the previously announced Phase 2b results in MG. Read the full MOA publication: bit.ly/3Yvz0fC Read the full Phase 2b publication: bit.ly/4jtv1JU

We’ve highlighted our recent progress and outlined Cartesian’s 2026 strategic priorities across our pipeline of mRNA cell therapy candidates for the treatment of #autoimmune diseases. Learn more about what we have in store for this year: bit.ly/3NljReh

We are excited to be in-person in San Francisco this year during #JPM2026 and look forward to connecting with the #biotech community to discuss Cartesian’s recent progress and strategic priorities in 2026 across our pipeline of mRNA cell therapies for #autoimmune diseases.

We’re happy to welcome Dr. Adrian Bot to Cartesian’s Board of Directors! His expertise will be particularly valuable while we continue to advance our current pipeline and explore potential opportunities beyond ex-vivo cell therapy! More here: bit.ly/49jXU7V

Our commitment to patients drives everything we do. The AURORA Phase 3 trial is evaluating a potential new treatment option for myasthenia gravis (#MG), designed for convenient outpatient dosing and no pretreatment chemo. See if you may qualify: myastheniagravis.study.science

We had a great time at our annual #Thanksgiving party! Thanks to our partnership with Beyond Shelter Frederick, we were able to give back to our community by hosting a supply drive to help in their mission of preventing and alleviating the effects of poverty in Frederick County.

Following our launch of "The Might and Grace Networkᵀᴹ - A MG Patient Ambassador Program", we hosted a patient ad-board with ambassadors living with gMG or caring for loved ones who are, to gain a deeper understanding of their lived experiences and treatment journeys.

We are excited to announce updated results from our Phase 2 trial of Descartes-08 in participants with #SLE, with a 100% LLDAS response rate in participants who received Descartes-08, in addition to our expansion into myositis. Read more: bit.ly/4hZkJ3t

Today we reported third quarter 2025 financial results and provided a business update. Full press release: bit.ly/4nNp4rX #celltherapy #autoimmunity

We joined @MyastheniaOrg Community Health Fairs Walk in D.C., walking with patients, caregivers, and supporters to raise awareness for #myastheniagravis. We’re proud to support this inspiring community and help advance care for those impacted. Learn more: bit.ly/47kBjra

October brought some extra fun to Cartesian! To get into the spirit, we celebrated the season with creative costumes and fall treats. Shoutout to our Manufacturing team for winning Best Overall Costume as Gru and his Minions, well deserved! Thanks to everyone who joined in!